• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERVASCULAR SAS INTERGARD KNITTED ULTRATHIN; VASCULAR POLYESTER GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERVASCULAR SAS INTERGARD KNITTED ULTRATHIN; VASCULAR POLYESTER GRAFT Back to Search Results
Model Number IGKUT0008-70
Device Problem Break (1069)
Patient Problem Pseudoaneurysm (2605)
Event Date 10/04/2016
Event Type  Injury  
Manufacturer Narrative
A review of the device history records indicated that the graft was processed and inspected according to procedures and was therefore released following acceptable quality inspections and tests.Specifically, no anomaly was evidenced in the mechanical resistance tests records.The investigation is still on going.A follow-up report will be submitted upon completion of the investigation.
 
Event Description
A cross femoro femoral bypass was performed on (b)(6) 2014 with the involved graft.Two years after implantation, it was reported on (b)(6) 2016 that the patient presents a false aneurysm in the path of the graft likely related to a breach of the graft frame.A scanner is scheduled for further surgery (removal of the graft).
 
Manufacturer Narrative
The case has been submitted to our vice president, medical affairs.Pictures of the explanted graft as well as pictures of the patient before explantation were also provided.From his preliminary opinion, he noticed traces of blood onone edge of the explanted graft.Also he indicated that the fibrotic tissue covering the graft appeared to be incomplete.This is an indication that there was a possible leakage coming from the anastomotic site that through the years created a false aneurysm.According to him, this is a complication of vascular vessels repair/replacement.Additional information has been requested to the surgeon.In addition, the explanted device was sent to a external and independent laboratory for macroscopic analysis.A follow-up report will be sent to your attention upon completion of the investigation.
 
Event Description
The graft was explanted on (b)(6) 2016.
 
Manufacturer Narrative
Additional information has been requested to the surgeon.However, in spite of repeated efforts, no information could be obtained.((b)(4)) the explanted device was sent to an external and independent laboratory for analysis.As no information was received from the surgeon, a full analysis has been requested to the external laboratory : - histopathological analysis in order to identify any signs of infection (if feasible, depending on the storage conditions) - enzymatic digestion of the tissues followed by macroscopic examination in order to identify: any tear, hole or break of the textile structure the integrity of the graft edges - sem examination of any abnormality found by macroscopic examination.It should be noted that additional delay was necessary due to some difficulties encountered for the enzymatic digestion of the tissues.Indeed, the laboratory decided to change the enzyme.The histopathologic analysis pointed out signs of infection and leakage (no endothelium, no extracellular matrix, signs of blood material from lumen to external side).Macroscopically, no signs of tear, hole or break of the textile structure were observed.The edges of the graft material (anastomotic junction) were not present.The conclusion of the external analysis was submitted to our corporate medical officer for his review.From his medical opinion, the analysis confirms the preliminary assessment made and is as follows : "it appears the false aneurysm was formed with time from a leakage.Despite the edges of the anastomosis are not contained in the sample, the analysis also confirms the integrity of the graft walls therefore it appears that the device was not the cause of the false lumen formation and it functioned as expected." ((b)(4)) the outcome of the investigation, which included the analysis performed on the explanted device, confirms the integrity of the graft walls.Therefore it appears that the device was not the cause of the false lumen formation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERGARD KNITTED ULTRATHIN
Type of Device
VASCULAR POLYESTER GRAFT
Manufacturer (Section D)
INTERVASCULAR SAS
zi athelia 1
la ciotat cedex, 13705
FR  13705
Manufacturer (Section G)
INTERVASCULAR SAS
zi athelia 1
la ciotat cedex, 13705
FR   13705
Manufacturer Contact
laure fraysse
zi athélia 1
la ciotat cedex, 13705
FR   13705
3344208464
MDR Report Key6050132
MDR Text Key58130103
Report Number1640201-2016-00031
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00384401001171
UDI-Public00384401001171
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K983819
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup
Report Date 10/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date03/31/2019
Device Model NumberIGKUT0008-70
Device Catalogue NumberIGKUT0008-70
Device Lot Number14D10
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer11/28/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/05/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-